Kaitlin Branick, MD
Pulmonary Disease · Sioux Falls, SDNPI 1093245912
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (46.6%), education and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 93.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $4,239 and has fallen 98.8% since, to $51 in 2025.
Across 24 payments — averaging $190.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Genentech USA, Inc.$144
- United Therapeutics Corporation$80
- Edwards Lifesciences$25
- Inspire Medical Systems, Inc.$21
- Insmed, Inc.$17
- plus $16 from 1 others
What the payments were for
- Travel & lodging$2,13247%
- Food & beverage$91420%
- Education$1,51733%
- Gifts$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 18 | $4,269 |
| Genentech USA, Inc. | 1 | $144 |
| United Therapeutics Corporation | 1 | $80 |
| Edwards Lifesciences | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Insmed, Inc. | 1 | $17 |
| La Jolla Pharmaceutical Company | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,913
- Activase$144
How this compares
$4,572 in reported general payments places this provider in the 70th percentile of 35 pulmonary disease providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 147 | $94,199 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 65 | $40,596 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 49 | $23,479 |
| Spiriva RespimatTiotropium Bromide | 40 | $23,014 |
| Advair HfaFluticasone Propion/Salmeterol | 38 | $14,331 |
| Breo ElliptaFluticasone/Vilanterol | 27 | $10,202 |
| Arnuity ElliptaFluticasone Furoate | 24 | $5,737 |
| Incruse ElliptaUmeclidinium Bromide | 15 | $5,111 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 32 | $4,037 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 131 | $3,068 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 24 | $2,902 |
| Ventolin HfaAlbuterol Sulfate | 44 | $2,294 |
| Roflumilast | 21 | $1,020 |
| Azithromycin | 30 | $409 |
| Montelukast Sodium | 65 | $364 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Sioux Falls
- Joevasanth DevasahayamSioux Falls$8K
- Matthew TaylorSioux Falls$8K
- Fady JamousSioux Falls$6K
- Rizan HajalSioux Falls$5K
- Anna PlemmonsSioux Falls$3K
- Mohammed AwadSioux Falls$2K
- Ashraf ElshamiSioux Falls$2K
- John YuSioux Falls$2K
- Rajaganesh RajagopalanSioux Falls$964
- Ross BaconSioux Falls$599
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.